Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Delgado

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|April 27, 2024
InsT-ALLing CD7 chimeric antigen receptors before transplantationJulio Delgado
Current Cancer Drug Targets|August 12, 2008
Novel epigenetic targets in lymphoproliferative disordersJulio Delgado
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Immobilizing A Moving Target: CAR T Cells Hit CD22Sonia Guedan, Julio Delgado
Medicina Clinica|July 20, 2016
[Advances in the treatment of chronic lymphocytic leukaemia]Pablo Mozas, Julio Delgado
Thescientificworldjournal|January 25, 2011
Practical aspects of allogeneic hematopoietic cell transplantation for patients with poor-risk chronic lymphocytic leukemiaJulio Delgado, Rafael F Duarte
Blood Reviews|August 1, 2009
Emerging therapies for patients with advanced chronic lymphocytic leukaemiaJulio Delgado, Javier Briones, Jorge Sierra
Best Practice & Research. Clinical Haematology|October 16, 2016
Present and future of personalized medicine in CLLEmili Montserrat, Tycho Bauman, Julio Delgado
Blood|July 31, 2009
Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?Julio Delgado, Donald W Milligan, Peter Dreger
Therapeutic Advances in Hematology|December 2, 2016
The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemiaValentín Ortíz-Maldonado, Pablo Mozas, Julio Delgado
Expert Opinion on Pharmacotherapy|February 25, 2014
New treatment options for chronic lymphocytic leukemiaJulio Delgado, Tycho Baumann, Rodrigo Santacruz, et al.
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|April 27, 2024
InsT-ALLing CD7 chimeric antigen receptors before transplantationJulio Delgado
Current Cancer Drug Targets|August 12, 2008
Novel epigenetic targets in lymphoproliferative disordersJulio Delgado
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Immobilizing A Moving Target: CAR T Cells Hit CD22Sonia Guedan, Julio Delgado
Medicina Clinica|July 20, 2016
[Advances in the treatment of chronic lymphocytic leukaemia]Pablo Mozas, Julio Delgado
Thescientificworldjournal|January 25, 2011
Practical aspects of allogeneic hematopoietic cell transplantation for patients with poor-risk chronic lymphocytic leukemiaJulio Delgado, Rafael F Duarte
Blood Reviews|August 1, 2009
Emerging therapies for patients with advanced chronic lymphocytic leukaemiaJulio Delgado, Javier Briones, Jorge Sierra
Best Practice & Research. Clinical Haematology|October 16, 2016
Present and future of personalized medicine in CLLEmili Montserrat, Tycho Bauman, Julio Delgado
Blood|July 31, 2009
Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?Julio Delgado, Donald W Milligan, Peter Dreger
Therapeutic Advances in Hematology|December 2, 2016
The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemiaValentín Ortíz-Maldonado, Pablo Mozas, Julio Delgado
Expert Opinion on Pharmacotherapy|February 25, 2014
New treatment options for chronic lymphocytic leukemiaJulio Delgado, Tycho Baumann, Rodrigo Santacruz, et al.
Pageof 24